DrugPatentWatch Database Preview

AMPHADASE Drug Profile

Email this page to a colleague

« Back to Dashboard

Summary for Tradename: AMPHADASE

Patents:	479
Applicants:	1
BLAs:	1
Drug Prices:	Drug price information for AMPHADASE
Recent Clinical Trials:	See clinical trials for AMPHADASE
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for AMPHADASE

See drug prices for AMPHADASE

Recent Clinical Trials for AMPHADASE

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Amphastar Pharmaceuticals, Inc.	Phase 2

See all AMPHADASE clinical trials

Recent Litigation for AMPHADASE

Identify key patents and potential future biosimilar entrants

District Court Litigation

Case Name	Date
KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC	2018-11-09
Halozyme, Inc. v. Lee	2016-12-19
Altair Instruments, Inc v. Kelley West Enterprises, LLC	2015-10-15

See all AMPHADASE litigation

PTAB Litigation

Petitioner	Date
	2017-05-30
	2017-01-31

See all AMPHADASE litigation

Patent Text Search: US Patents for AMPHADASE

These patents were identified by searching patent claims

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Amphastar Pharm	AMPHADASE	hyaluronidase	INJECTABLE;INJECTION	021665	001	2005-11-03		Oxyrane UK Limited (Manchester, GB)	2030-09-29	RX		search
Amphastar Pharm	AMPHADASE	hyaluronidase	INJECTABLE;INJECTION	021665	001	2005-11-03		SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	RX		search
Amphastar Pharm	AMPHADASE	hyaluronidase	INJECTABLE;INJECTION	021665	001	2005-11-03		Halozyme, Inc. (San Diego, CA)	2023-03-05	RX		search
Amphastar Pharm	AMPHADASE	hyaluronidase	INJECTABLE;INJECTION	021665	001	2005-11-03		Oxyrane UK Limited (Manchester, GB) VIB vzw (Ghent, BE) Universiteit Gent (Ghent, BE)	2027-04-03	RX		search
Amphastar Pharm	AMPHADASE	hyaluronidase	INJECTABLE;INJECTION	021665	001	2005-11-03		Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V. (DE) Asklepios Kliniken Verwaltungsgesellschaft mbH (DE)	2033-12-05	RX		search
Amphastar Pharm	AMPHADASE	hyaluronidase	INJECTABLE;INJECTION	021665	001	2005-11-03		Regenerative Research Foundation (Rensselaer, NY)	2028-04-22	RX		search
Amphastar Pharm	AMPHADASE	hyaluronidase	INJECTABLE;INJECTION	021665	001	2005-11-03		Agency for Science, Technology and Research (Singapore, SG)	2033-02-13	RX		search

International Patents for AMPHADASE

Country	Patent Number	Estimated Expiration
Argentina	074106
Canada	1217717
Israel	227617
South Korea	20040104967
Canada	2804973
China	1553952
World Intellectual Property Organization (WIPO)	9951170

Supplementary Protection Certificates for AMPHADASE

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
300907	Netherlands		PRODUCT NAME: DEOXYCHOLINEZUUR NATRIUMZOUT
47/2013	Austria		PRODUCT NAME: OCRIPLASMIN; REGISTRATION NO/DATE: EU/1/13/819/001 (MITTEILUNG) 20130315
122015000061	Germany		PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
PA2013020	Lithuania		PRODUCT NAME: OCRIPLASMINUM (MICROPLASMINUM); REGISTRATION NO/DATE: EU/1/13/819/001 20130313
300822	Netherlands		PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
PA2016022	Lithuania		PRODUCT NAME: RITUKSIMABAS; REGISTRATION NO/DATE: EU/1/98/067/001-002 20140321
122018000065	Germany		PRODUCT NAME: DEOXYCHOLSAEURE NATRIUMSALZ; NAT. REGISTRATION NO/DATE: 98586.00.00 20180104; FIRST REGISTRATION: IS IS/1/16/071/01 20160729